Multiple Myeloma Posts on Medivizor
Navigation Menu

Multiple Myeloma Posts on Medivizor

Stem cell transplantation and lenalidomide improves survival of patients with multiple myeloma

Posted by on Dec 5, 2018 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of high-dose therapy with autologous stem cell transplantation (HDT-ASCT) and maintenance treatment (treatment meant to keep cancer from coming back) with lenalidomide (Revlimid) for patients with multiple myeloma. The authors concluded that this therapy is safe...

Read More

Is Daratumumab added to bortezomib plus dexamethasone better in treating multiple myeloma?

Posted by on Nov 28, 2018 in Multiple Myeloma | 0 comments

In a nutshell This article investigated the safety and effectiveness of adding daratumumab (Darzalex) to bortezomib (Velcade) and dexamethasone (Decadron) for the treatment of relapsed or refractory (does not respond to treatment) multiple myeloma (RRMM). The authors concluded that the addition of daratumumab is safe and gave the greatest benefit to...

Read More

How does elotuzumab affect pain and quality of life in non-responsive multiple myeloma?

Posted by on Nov 19, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study investigated the effects of adding elotuzumab to lenalidomide and dexamethasone to treat un-responsive multiple myeloma. The main finding was that patients treated with elotuzumab responded better to lenalidomide and dexamethasone. Some background Many patients respond well to treatment for multiple myeloma (MM). However some...

Read More

Thalidomide for Multiple Myeloma.

Posted by on Nov 7, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study aimed to compare the long-term effects of thalidomide (Immunoprin) to those of classic anti-cancer drugs in patients with recently diagnosed multiple myeloma. Thalidomide appeared effective but many patients experienced side-effects that affected treatment.  Some background Vincristine (Oncovin), doxorubicin...

Read More

The safety of elotuzumab, lenalidomide and dexamethasone in unresponsive multiple myeloma.

Posted by on Oct 18, 2018 in Multiple Myeloma | 0 comments

In a nutshell This paper compared the safety and effectiveness of elotuzumab (Empliciti) plus lenalidomide (Revlimid) and dexamethasone (Decadron) with lenalidomide and dexamethasone in unresponsive multiple myeloma. It was found that elotuzumab plus lenalidomide and dexamethasone was more effective than lenalidomide and dexamethasone alone. Some...

Read More

“Your Life Depends on Your Own Advocacy”

“Your Life Depends on Your Own Advocacy”

Posted by on Sep 10, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 1 comment

“Always trust your gut. Don’t leave your treatment in the hands of someone that you don’t trust or that does not seem like a team player. Yes, they are all smart—even brilliant—but read, read, read, and question them at every corner and challenge the standard of care. Exercise, healthy eating, learning the ropes of insurance, mediation/prayer...

Read More

Evaluating the risk of developing acute myeloid leukemia or myelodysplastic syndrome after a stem cell transplant

Posted by on Sep 4, 2018 in Multiple Myeloma | 0 comments

In a nutshell This study evaluated the risk of acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) development in patients with lymphoma and myeloma after an autologous stem cell transplant (autoSCT). This study concluded that this risk is quite high after autoSCT in these patients. Some background AML and MDS are known long-term...

Read More

Clinical Trials Today

Clinical Trials Today

Posted by on Aug 26, 2018 in Benign prostatic hyperplasia, Blog, Breast cancer, Colorectal cancer, Coronary artery disease, Diabetes mellitus, Erectile dysfunction, Hodgkin's lymphoma, Hypertension, Infertility, Kidney stones, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Nocturia, Non-Hodgkin lymphoma, Overactive bladder, Parkinson's Disease, Prostate cancer, Rheumatoid Arthritis, Stroke, Urinary incontinence, Urinary tract infection | 4 comments

Prior to the 20th century, most people lived about 47 years in the developed world because of infectious diseases. In 1940, the first use of penicillin to treat infectious diseases occurred and penicillin became available in 1945 to the general public. Science and research conducted throughout the 1950s, 60s, and 70s, created more antibiotics so that life...

Read More

Cancer Vaccines

Cancer Vaccines

Posted by on Aug 13, 2018 in Blog, Breast cancer, Colorectal cancer, Hodgkin's lymphoma, Leukemia, Lung cancer, Lymphoma, Melanoma, Multiple Myeloma, Non-Hodgkin lymphoma, Prostate cancer | 4 comments

When I think of vaccines, I think of the MMRV (measles, mumps, rubella and varicella) vaccines which help our bodies establish immunity against diseases that used to kill.  Now, there are vaccines being created for cancer. The rise of cancer vaccines According to Dr. Nora Disis, an oncologist and researcher in cancer vaccines at the University of...

Read More